Document is current

Article History

Received: 2 April 2020

Accepted: 30 May 2020

First Online: 29 June 2020

Ethics approval and consent to participate

: Not applicable.

: All authors and all meeting participants gave their informed consent.

: A Bonertz, S Kaul, V Mahler, D Mentzer and S Vieths reports not having competing interests.J Bousquet reports personal fees and other from Chiesi, Cipla, Hikma, Menarini, Mundipharma, Mylan, Novartis, Sanofi-Aventis, Takeda, Teva, Uriach, outside the submitted work.P Eigenmann reports personal fees and other from ThermoFisher Scientific, DBV technologies, Nestlé, Danone, Abbott, Novartis, ALK, UpToDate, Wiley and Elsevier, outside the submitted work.S Halken reports personal fees and non-financial support from ALK-Abelló, outside the submitted work.M Jutel reports personal fees from ALK-Abello, personal fees from Allergopharma, personal fees from Stallergenes, personal fees from Anergis, personal fees from Allergy Therapeutics, personal fees from Circassia, personal fees from Leti, personal fees from Biomay, personal fees from HAL, during the conduct of a study; personal fees from Astra-Zeneka, personal fees from GSK, personal fees from Novartis, personal fees from Teva, personal fees from Vectura, personal fees from UCB, personal fees from Takeda, personal fees from Roche, personal fees from Janssen, personal fees from Medimmune, personal fees from Chiesi, outside the submitted work.A Muraro reports speaker’s fees from: Aimmune, DBV, Nestlé-Health Institute, Nestlé Purina, Nutricia, ALK, HAL outside the submitted work.O Pfaar reports grants and personal fees from ALK-Abelló, grants and personal fees from Allergopharma, grants and personal fees from Stallergenes Greer, grants and personal fees from HAL Allergy Holding B.V./HAL Allergie GmbH, grants and personal fees from Bencard Allergie GmbH/Allergy Therapeutics, grants and personal fees from Lofarma, grants from Biomay, grants from Circassia, grants and personal fees from ASIT Biotech Tools S.A., grants and personal fees from Laboratorios LETI/LETI Pharma, personal fees from MEDA Pharma/MYLAN, grants and personal fees from Anergis S.A., personal fees from Mobile Chamber Experts (a GA2LEN Partner), personal fees from Indoor Biotechnologies, grants from Glaxo Smith Kline, personal fees from Astellas Pharma Global, personal fees from EUFOREA, personal fees from ROXALL, personal fees from NOVARTIS, personal fees from SANOFI AVENTIS, outside the submitted work.U Wahn reports lecture and consultation fees from Novartis, Sanofi-Aventis, Berlin-Chemie, StallergenesGreer, ALK, Leti, and Roxall.